Bronchially instilled IgY-antibodies did not decrease pulmonary P. aeruginosa concentration in experimental porcine pneumoniaVisa övriga samt affilieringar
2021 (Engelska)Ingår i: Acta Anaesthesiologica Scandinavica, ISSN 0001-5172, E-ISSN 1399-6576, Vol. 65, nr 5, s. 656-663Artikel i tidskrift (Refereegranskat) Published
Abstract [en]
BACKGROUND: P. aeruginosa possesses antibiotic resistance, making treatment difficult. Polyclonal anti-P. aeruginosa IgY-antibodies (Pa-IgY) have antibacterial effects, but have not been studied in large animal pneumonia.
OBJECTIVES: To test if Pa-IgY decreases the concentration of P. aeruginosa in broncho-alveolar lavage in experimental porcine pneumonia over 27 hours.
METHOD: Norwegian landrace pigs were anesthetized, mechanically ventilated and subject to invasive monitoring. The animals were randomized to receive either P. aeruginosa (control, n=12) or P. aeruginosa + Pa-IgY antibodies with a repeated dose of Pa-IgY after 12 hours (intervention, n=12) in the right lower pulmonary lobe. Bronchoalveolar lavage (BAL) cultures and physiological measurements were obtained repeatedly for 27 hours after which the pigs were sacrificed.
RESULTS: in the control group (n.s.). The intervention group had lower heart rate (p<0.001), lower cardiac index (p<0.01) and lower arterial lactate (p<0.001) compared to the control group. The core temperature was lower in the intervention group than in the control group (p<0.001).
CONCLUSION: The chosen dose of Pa-IgY did not decrease concentrations of P. aeruginosa in BAL over 27 hours. We conclude that it is unlikely that there is a large effect of this specific dose and route of administration of Pa-IgY in this type of model.
Ort, förlag, år, upplaga, sidor
Wiley-Blackwell Publishing Inc., 2021. Vol. 65, nr 5, s. 656-663
Nyckelord [en]
Anti-bacterial agents, drug resistance (microbial), healthcare-associated pneumonia, ventilator-associated pneumonia
Nationell ämneskategori
Anestesi och intensivvård
Identifikatorer
URN: urn:nbn:se:oru:diva-88947DOI: 10.1111/aas.13784ISI: 000616716700001PubMedID: 33481246Scopus ID: 2-s2.0-85100977679OAI: oai:DiVA.org:oru-88947DiVA, id: diva2:1522985
Forskningsfinansiär
Vinnova, 2016-04083
Anmärkning
Funding Agencies:
Region Örebro research fund
Uppsala University hospital research fund
2021-01-272021-01-272021-05-26Bibliografiskt granskad